News and Opinion - Page 2 of 15 - IPHA

News and Opinion

October 10, 2022

Three in five people expect another Covid-19 ‘wave’ this year, says Ipsos survey for IPHA

84% of people believe Ireland would be better prepared for another pandemic due to our experience with Covid-19 Trust in vaccines remains high, with 79% of […]
September 27, 2022

Budget’s €18m for new medicines falls short of amount needed to optimise patients’ access to innovation

Budget’s €18m for new medicines falls short of amount needed to optimise patients’ access to innovation Originator industry acknowledges extraordinary pressures facing the Government but the […]
September 26, 2022

Europe’s planned legislative overhaul is a chance to make our voices count, writes Bernard Mallee

In the coming weeks, the Government will publish a White Paper on Enterprise. It will explore strategic policy options facing the enterprise sector. It comes as […]
September 14, 2022

Biogen’s Michael O’Connell named as new IPHA President

Biogen’s Michael O’Connell named as new IPHA President Takeda’s Shane Ryan confirmed as Vice-President as industry focuses on a better environment for access, competitiveness and innovation […]
July 4, 2022

Two in five people believe pandemic will never be fully over, says Ipsos survey for IPHA

Two in five people believe pandemic will never be fully over, says Ipsos survey for IPHA Half of people believe Covid-19 pandemic will eventually end while […]
June 20, 2022

Over half the public has favourable opinion about pharmaceutical industry, says Ipsos survey for IPHA

Over half the public has favourable opinion about pharmaceutical industry, says Ipsos survey for IPHA Latest research shows public values science and the industry’s local societal […]
June 20, 2022

Give patients faster access to new medicines, writes Bernard Mallee

Irish patients deserve faster access to the best new medicines. We are slower than almost every other western European country to give the latest medicines to […]
June 19, 2022

Europe faces choice between innovation or the risk of stagnation, writes Bernard Mallee

A quarter of a century ago, almost half of global new treatments originated in Europe. Today, the proportion has dropped to 22%. The United States has […]
May 23, 2022

Ireland attracts fewer clinical trials than peer countries in Europe, says IPHA survey

More process efficiency urged as data shows Finland and Denmark outperform Ireland in drawing research activity Ireland is attracting fewer clinical trials than some European countries […]